Prognostic indicators of KRAS G12X mutations in pancreatic cancer.

被引：0
|
作者：
Ardalan, Bach
Ciner, Aaron
Baca, Yasmine
Darabi, Sourat
Kasi, Anup
Lou, Emil
Azqueta, Jose Ignacio
Xiu, Joanne
Nabhan, Chadi
Shields, Anthony Frank
Pishvaian, Michael J.
Korn, Wolfgang Michael
Goel, Sanjay
机构：
[1] Univ Miami, Miami, FL USA
[2] Univ Maryland, Baltimore, MD 21201 USA
[3] Caris Life Sci, Phoenix, AZ USA
[4] Hoag Family Canc Inst, Newport Beach, CA USA
[5] Univ Kansas Med Ctr, Westwood, KS USA
[6] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA
[7] Univ Miami, Sylvester Canc Ctr, Miami, FL USA
[8] Barbara Ann Karmanos Canc Inst, Detroit, MI USA
[9] Johns Hopkins Univ, Sch Med, Washington, DC USA
[10] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
735
引用
收藏
页码：735 / 735
页数：1
相关论文
共 50 条
  • [31] Targeting KRAS-regulated metabolic activities in pancreatic cancer.
    Bryant, Kirsten L.
    Hobbs, G. Aaron
    Der, Channing J.
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 21 - 22
  • [32] Understanding the tumor extrinsic role of oncogenic Kras in pancreatic cancer.
    Bonilla, Monica E.
    CANCER RESEARCH, 2022, 82 (22) : 157 - 157
  • [33] The prognostic value of KRAS mutation in locally advanced rectal cancer.
    Bakalov, Veli
    Hasan, Shaakir
    Abel, Stephen
    Babar, Laila
    Shaikh, Hira
    Raj, Moses S.
    Finley, Gene Grant
    Monga, Dulabh K.
    Kirichenko, Alexander V.
    Wegner, Rodney E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] The prognostic value of HRD mutations in liver cancer.
    Chen, Jinzhang
    Huang, Tanxiao
    Liu, Ming
    Liao, Wenting
    Fu, Mimi
    Yang, Bo
    Duan, Jingxian
    Chen, Shifu
    Guo, Yabing
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] Plasma cell-free DNA and fraction of circulating KRAS mutations as prognostic in patients with metastatic colorectal cancer.
    Sefrioui, David
    Vasseur, Nasrin
    Sesbouee, Richard
    Blanchard, France
    Oden-Gangloff, Alice
    Sabourin, Jean-Christophe
    Frebourg, Thierry
    Michel, Pierre
    Di Fiore, Frederic
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [36] Prognostic impact of KRAS mutation subtype and concurrent genetic mutations in non-small cell lung cancer.
    Aredo, Jacqueline
    Padda, Sukhmani Kaur
    Kunder, Christian
    Han, Summer S.
    Wakelee, Heather A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] Enhancements in pancreatic protocol CT as a prognostic indicator in pancreatic cancer.
    Park, Jaewon
    Cho, In Kuk
    Lee, Jong-Chan
    Lee, Jongchan
    Kim, Young Hoon
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [38] The prognostic value of mutational signatures in pancreatic cancer.
    Light, Nicholas
    Zhang, Amy
    Hamza, Oumaima
    Jang, Gun Ho
    Dodd, Anna
    Wilson, Julie
    O'Kane, Grainne M.
    Tsang, Erica S.
    Notta, Faiyaz
    Knox, Jennifer J.
    Gallinger, Steven
    Grant, Robert C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 689 - 689
  • [39] Molecular Epidemiology of KRAS G12C Mutations in Chinese Lung Cancer Patients
    Loong, H.
    Du, N.
    Cheng, C.
    Lin, H.
    Guo, J.
    Lin, G.
    Li, M.
    Jiang, T.
    Shi, Z.
    Cui, Y.
    Jin, X.
    Yao, J.
    Xing, Y.
    Yao, M.
    Wang, K.
    Mok, T.
    Liu, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S426 - S426
  • [40] KRAS G12C mutations in non-small cell lung cancer
    Li, J. J.
    Wu, X. J.
    Farzin, M.
    Bray, V.
    Williamson, J.
    Pal, A.
    Yip, P. Y.
    Hagelamin, A.
    Ding, P.
    Nindra, U.
    Vinod, S.
    French, B.
    Chua, W.
    Gupta, R.
    Cooper, W. A.
    Wang, B.
    Lee, C. S.
    HISTOPATHOLOGY, 2024, 85 : 25 - 25
12345